Emerging Infectious Diseases (May 2022)

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

  • Jackie Kleynhans,
  • Stefano Tempia,
  • Nicole Wolter,
  • Anne von Gottberg,
  • Jinal N. Bhiman,
  • Amelia Buys,
  • Jocelyn Moyes,
  • Meredith L. McMorrow,
  • Kathleen Kahn,
  • F. Xavier Gómez-Olivé,
  • Stephen Tollman,
  • Neil A. Martinson,
  • Floidy Wafawanaka,
  • Limakatso Lebina,
  • Jacques D. du Toit,
  • Waasila Jassat,
  • Mzimasi Neti,
  • Marieke Brauer,
  • Cheryl Cohen

DOI
https://doi.org/10.3201/eid2805.220278
Journal volume & issue
Vol. 28, no. 5
pp. 1055 – 1058

Abstract

Read online

By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.

Keywords